Oseltamivir orally disintegrating tablets(Hefei Industrial Pharma)

奥司他韦口崩片（合肥医工医药）

Report date: 2025/10/30 14:39:02

Base Information

Drug NameOseltamivir orally disintegrating tablets(Hefei Industrial Pharma)
Drug Alias NameHY-100209 口崩片奥司他韦口崩片（2.2类改良型）HY-100209
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Prodrug
Mechanisms of ActionNeuraminidase inhibitors
TargetsNeuraminidase
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHefei Industrial Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHefei Industrial Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG